NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Index- P/E- EPS (ttm)-51.76 Insider Own11.05% Shs Outstand3.64M Perf Week20.80%
Market Cap5.49M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.23M Perf Month-29.11%
Income-5.13M PEG- EPS next Q- Inst Own4.53% Short Float4.37% Perf Quarter-47.39%
Sales34.87M P/S0.16 EPS this Y- Inst Trans0.60% Short Ratio0.10 Perf Half Y-51.91%
Book/sh9.10 P/B0.17 EPS next Y- ROA-17.73% Short Interest0.14M Perf Year-93.76%
Cash/sh2.66 P/C0.57 EPS next 5Y- ROE-22.97% 52W Range1.17 - 23.80 Perf YTD-49.67%
Dividend Est.- P/FCF- EPS past 5Y82.07% ROI-21.18% 52W High-93.66% Beta1.25
Dividend TTM- Quick Ratio2.33 Sales past 5Y551.91% Gross Margin29.95% 52W Low29.14% ATR (14)0.23
Dividend Ex-Date- Current Ratio4.11 EPS Y/Y TTM86.42% Oper. Margin-16.52% RSI (14)43.23 Volatility16.61% 17.11%
Employees52 Debt/Eq0.04 Sales Y/Y TTM44.75% Profit Margin-14.72% Recom1.00 Target Price15.00
Option/ShortNo / Yes LT Debt/Eq0.03 EPS Q/Q99.20% Payout- Rel Volume0.11 Prev Close1.55
Sales Surprise-28.52% EPS Surprise99.82% Sales Q/Q24.93% EarningsNov 06 BMO Avg Volume1.43M Price1.51
SMA20-2.64% SMA50-23.57% SMA200-48.89% Trades Volume160,552 Change-2.58%
Apr-21-25 08:30AM
Apr-03-25 10:50AM
Apr-02-25 01:20PM
08:00AM
Apr-01-25 05:09PM
09:06AM Loading…
Mar-25-25 09:06AM
Mar-10-25 09:00AM
Jan-21-25 08:00AM
Jan-15-25 08:00AM
Dec-09-24 07:30AM
Dec-04-24 04:05PM
Dec-02-24 08:00AM
Nov-22-24 08:00AM
Nov-06-24 08:00AM
Sep-26-24 08:00AM
09:15AM Loading…
Sep-04-24 09:15AM
08:30AM
08:00AM
Aug-26-24 08:00AM
Aug-19-24 08:00AM
Aug-16-24 10:53PM
Aug-06-24 08:00AM
Jun-28-24 06:00AM
Jun-20-24 02:51PM
May-21-24 08:00AM
May-20-24 09:54PM
May-16-24 06:15AM
Apr-19-24 08:00AM
Apr-12-24 09:00AM
Apr-08-24 01:53PM
08:00AM Loading…
Apr-01-24 08:00AM
Mar-04-24 09:18AM
Feb-15-24 09:15AM
Feb-13-24 09:00AM
Dec-04-23 08:30AM
Nov-13-23 08:30AM
Sep-21-23 09:05PM
Aug-11-23 08:30AM
May-16-23 02:15PM
09:58AM
May-12-23 08:00AM
May-11-23 09:00AM
Apr-05-23 08:00AM
Feb-28-23 07:30AM
Feb-10-23 07:35AM
Jan-19-23 07:30AM
Dec-27-22 08:00AM
Dec-20-22 08:00AM
Nov-23-22 11:20AM
Nov-16-22 10:12AM
08:00AM
Nov-13-22 07:52AM
Nov-07-22 09:28AM
Oct-20-22 08:00AM
07:32AM
Aug-08-22 08:15AM
Aug-04-22 08:00AM
Jul-28-22 08:10AM
Jun-27-22 05:30AM
Apr-28-22 04:50PM
09:20AM
Apr-26-22 08:13AM
12:41AM
Apr-25-22 08:00AM
Apr-19-22 06:45PM
02:02PM
Apr-08-22 09:44AM
Apr-05-22 03:45PM
01:41PM
08:00AM
07:30AM
Mar-15-22 09:45AM
Mar-14-22 06:12PM
Mar-10-22 09:17AM
Feb-25-22 08:00AM
Feb-17-22 10:40AM
10:07AM
Feb-15-22 09:00AM
Dec-22-21 08:52AM
Nov-03-21 12:35PM
Oct-06-21 08:00AM
Aug-12-21 09:00AM
Jul-27-21 09:00AM
Jul-20-21 09:00AM
Jul-08-21 09:00AM
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Fort Lauderdale, FL.